These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15194910)

  • 1. Phase I clinical evaluation of citrate-coated monocrystalline very small superparamagnetic iron oxide particles as a new contrast medium for magnetic resonance imaging.
    Taupitz M; Wagner S; Schnorr J; Kravec I; Pilgrimm H; Bergmann-Fritsch H; Hamm B
    Invest Radiol; 2004 Jul; 39(7):394-405. PubMed ID: 15194910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic resonance imaging of liver metastases: experimental comparison of anionic and conventional superparamagnetic iron oxide particles with a hepatobiliary contrast medium during dynamic and uptake phases.
    Kaufels N; Korn R; Wagner S; Schink T; Hamm B; Taupitz M; Schnorr J
    Invest Radiol; 2008 Jul; 43(7):496-503. PubMed ID: 18580332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monomer-coated very small superparamagnetic iron oxide particles as contrast medium for magnetic resonance imaging: preclinical in vivo characterization.
    Wagner S; Schnorr J; Pilgrimm H; Hamm B; Taupitz M
    Invest Radiol; 2002 Apr; 37(4):167-77. PubMed ID: 11923639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New generation of monomer-stabilized very small superparamagnetic iron oxide particles (VSOP) as contrast medium for MR angiography: preclinical results in rats and rabbits.
    Taupitz M; Schnorr J; Abramjuk C; Wagner S; Pilgrimm H; Hünigen H; Hamm B
    J Magn Reson Imaging; 2000 Dec; 12(6):905-11. PubMed ID: 11105029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Focal liver lesions: SPIO-, gadolinium-, and ferucarbotran-enhanced dynamic T1-weighted and delayed T2-weighted MR imaging in rabbits.
    Schnorr J; Wagner S; Abramjuk C; Drees R; Schink T; Schellenberger EA; Pilgrimm H; Hamm B; Taupitz M
    Radiology; 2006 Jul; 240(1):90-100. PubMed ID: 16684917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the iron oxide-based blood-pool contrast medium VSOP-C184 with gadopentetate dimeglumine for first-pass magnetic resonance angiography of the aorta and renal arteries in pigs.
    Schnorr J; Wagner S; Abramjuk C; Wojner I; Schink T; Kroencke TJ; Schellenberger E; Hamm B; Pilgrimm H; Taupitz M
    Invest Radiol; 2004 Sep; 39(9):546-53. PubMed ID: 15308937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary MR angiography using citrate-coated very small superparamagnetic iron oxide particles as blood-pool contrast agent: initial experience in humans.
    Wagner M; Wagner S; Schnorr J; Schellenberger E; Kivelitz D; Krug L; Dewey M; Laule M; Hamm B; Taupitz M
    J Magn Reson Imaging; 2011 Oct; 34(4):816-23. PubMed ID: 21769977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ultra-small superparamagnetic iron oxide particles: the signal behavior and relaxation times of the bone marrow after repeated i.v. application in the pig model at 1.5 tesla].
    Cihal S; Maas R; Delling G; Klich S; Nielsen P; Lodemann KP; Bücheler E
    Rofo; 1999 Aug; 171(2):149-54. PubMed ID: 10506890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I clinical evaluation of a new iron oxide MR contrast agent.
    McLachlan SJ; Morris MR; Lucas MA; Fisco RA; Eakins MN; Fowler DR; Scheetz RB; Olukotun AY
    J Magn Reson Imaging; 1994; 4(3):301-7. PubMed ID: 8061425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in predominant enhancement mechanisms of superparamagnetic iron oxide and ultrasmall superparamagnetic iron oxide for contrast-enhanced portal magnetic resonance angiography. Preliminary results of an animal study original investigation.
    Knollmann FD; Böck JC; Rautenberg K; Beier J; Ebert W; Felix R
    Invest Radiol; 1998 Sep; 33(9):637-43. PubMed ID: 9766048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety profile of ultrasmall superparamagnetic iron oxide ferumoxtran-10: phase II clinical trial data.
    Sharma R; Saini S; Ros PR; Hahn PF; Small WC; de Lange EE; Stillman AE; Edelman RR; Runge VM; Outwater EK; Morris M; Lucas M
    J Magn Reson Imaging; 1999 Feb; 9(2):291-4. PubMed ID: 10077027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MR venography using an intravascular contrast agent: results from a multicenter phase 2 study of dosage.
    Larsson EM; Sundén P; Olsson CG; Debatin J; Duerinckx AJ; Baum R; Hahn D; Ebner F
    AJR Am J Roentgenol; 2003 Jan; 180(1):227-32. PubMed ID: 12490510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ferrimagnetic susceptibility contrast agents.
    Bach-Gansmo T
    Acta Radiol Suppl; 1993; 387():1-30. PubMed ID: 8390776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary MR angiography: experimental results with a monomer-stabilized blood pool contrast medium.
    Taupitz M; Schnorr J; Wagner S; Abramjuk C; Pilgrimm H; Kivelitz D; Schink T; Hansel J; Laub G; Hünigen H; Hamm B
    Radiology; 2002 Jan; 222(1):120-6. PubMed ID: 11756715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac magnetic resonance angiography using blood-pool contrast agents: comparison of citrate-coated very small superparamagnetic iron oxide particles with gadofosveset trisodium in pigs.
    Schnorr J; Taupitz M; Schellenberger EA; Warmuth C; Fahlenkamp UL; Wagner S; Kaufels N; Wagner M
    Rofo; 2012 Feb; 184(2):105-12. PubMed ID: 22179768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superparamagnetic iron oxide particles (SH U 555 A): evaluation of efficacy in three doses for hepatic MR imaging.
    Shamsi K; Balzer T; Saini S; Ros PR; Nelson RC; Carter EC; Tollerfield S; Niendorf HP
    Radiology; 1998 Feb; 206(2):365-71. PubMed ID: 9457187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superparamagnetic particles as an oral contrast agent in abdominal magnetic resonance imaging.
    Oksendal AN; Jacobsen TF; Gundersen HG; Rinck PA; Rummeny E
    Invest Radiol; 1991 Nov; 26 Suppl 1():S67-70; discussion S71. PubMed ID: 1808152
    [No Abstract]   [Full Text] [Related]  

  • 18. Imaging of macrophages in soft-tissue infection in rats: relationship between ultrasmall superparamagnetic iron oxide dose and MR signal characteristics.
    Lutz AM; Weishaupt D; Persohn E; Goepfert K; Froehlich J; Sasse B; Gottschalk J; Marincek B; Kaim AH
    Radiology; 2005 Mar; 234(3):765-75. PubMed ID: 15665219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic MR imaging with ferumoxides: multicenter study of safety and effectiveness of direct injection protocol.
    Bluemke DA; Weber TM; Rubin D; de Lange EE; Semelka R; Redvanly RD; Chezmar J; Outwater E; Carlos R; Saini S; Holland GA; Mammone JF; Brown JJ; Milestone B; Javitt MC; Jacobs P
    Radiology; 2003 Aug; 228(2):457-64. PubMed ID: 12893904
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.